New Frontiers in Ophthalmology

We are delighted to announce the

VIII New Frontiers in Ophthalmology Meeting 2020

‘Fluid vs. Function in the Treatment of Wet AMD’

will take place as a virtual meeting

Thursday 8th October from 6pm to 7.45pm.

Register here

It has been a challenging year for all, and it gives us great pleasure to be able to bring this key educational event online, connect with our colleagues, and continue to provide a forum for learning and knowledge sharing in Ophthalmology.

This year’s theme ‘Fluid vs. Function in the Treatment of Wet AMD’ provides to be an opportunity to come together and discuss this important topic with our speakers;

Professor Matthew Campbell of the Smurfit Institute for Genetics, Trinity College Dublin, (Biography)

Professor Robin Hamilton of Moorfields Eye Hospital, London, (Biography)

Ms. Andrea Ryan of the Royal Victoria Eye and Ear Hospital, Dublin.

Chaired by Mr. Mark Cahill, Royal Victoria Eye and Ear Hospital, Dublin

Programme

This meeting has been awarded 2 External Points & 0.5 Internal CME Points  by the Irish College of Ophthalmology 

1 CPD credit is equivalent to 1 hour of educational activity

We look forward to your joining us on the 8th October and be part of connecting with colleagues and peers through the first virtual New Frontiers in Ophthalmology Meeting.

Register here

You will be provided with an access link to the meeting following registration.

This meeting is supported by

Ocular Inflammation

The 2018 New Frontiers in Ophthalmology took place on Thursday 7th June.
Always an important event in the calendar year, this year’s meeting again played host to expert speakers and international colleagues, focusing on advances in Ocular Inflammation

Speakers included

• Dr John Fitzsimons (Our Lady of Lourdes Hospital, Drogheda)
  Advances in the Diagnosis and Management of Allergy
• Mr Barry Quill (Royal Victoria Eye & Ear Hospital)
  Update on Ocular Allergy
• Dr Monica Berry (University of Bristol)
  Molecular chat: mucins, sugars and cells
• Athanasios Vardarinos
  Evidence on treat and extend Ranibizumab continues to build. Review of the RIVAL interim results and real-world outcomes
• Prof Elizabeth Vandenberghe (St James’s Hospital)
  The challenge of managing ocular Graft versus Host disease post stem cell transplantation
• Professor Friedrich Kruse (University of Erlangen, Germany)
  New frontiers in ocular surface disorders

• Professor John Crown, Consultant Medical Oncologist, St Vincents University Hospital, Dublin‘Drug Therapy of Ocular Melanoma’
• Professor Giuseppe Gullo, Consultant Medical Oncologist, St Vincents University Hospital, Dublin‘Survival in Uveal Melanoma: An Irish Patient Cohort’
• Dr. Arun Singh MD Cole Eye Institute Cleveland, Ohio, US‘Diagnosis of Uveal Melanoma – Pearls and Pitfalls’
• Dr. Arun Singh MD Cole Eye Institute Cleveland, Ohio, US‘Genetics of Uveal Melanoma – Recent Advances’

• Dr Paul Kenna, Director of Research, Royal Victoria Eye & Ear Research Foundation‘Inherited Retinal Degenerations – From Cause to ? Cure’
• Dr Sinead Connolly, Clinical Educator and Research Fellow, Royal College of Surgeons in Ireland‘Small Molecules with Big Potential – Nanoparticle Approaches in Ophthalmology’

Glaucoma Study Day

The meeting was chaired by Ms Aoife Doyle (Royal Victoria Eye & Ear Hospital).

Speakers included

• Prof Anthony J.W King (Nottingham University Hospital)
• Mr Jeremy O’Connor (Royal Victoria Eye & Ear Hospital)
• Yvonne Delaney (Bons Secour Hospital)
• Prof Colm O’Brien (Mater Misericordiae University Hospital)
• Ms Carol Hoang (Novartis Global Brand Medical Director)

• Prof Anthony King, Consultant Ophthalmic Surgeon, Honorary Clinical Professor of Ophthalmology, Nottingham University Hospital Surgery as initial intervention for advanced glaucoma
• Mr Jeremy O’Connor, Consultant Ophthalmic Surgeon, Royal Victoria Eye & Ear Hospital MIGS

Diabetic Retinopathy.

The New Frontiers in Ophthalmology Meeting was held on Thursday 12th June 2014 in the Education and Conference Centre of the Royal Victoria Eye & Ear Hospital.

Speakers included:

• Lloyd Paul Aiello (Harvard University)
• Mr Mark Cahill (Royal Victoria Eye & Ear Hospital)
• Dr Reinhold Medina (Queens University Belfast)
• Mr David Keegan (Mater Misericordiae University Hospital & Mater Private Hospital))
• Mr Rob Acheson (Mater Private Hospital))

Download the poster (PDF)

The meeting was sponsored by Novartis. The meeting had a excellent turnout and we received very positive feedback. We would like to thank the speakers Mr Mark Cahill (Chair), Prof Lloyd Paul Aiello, Dr Reinhold Medina, Mr David Keegan and Mr Rob Acheson and in particular Novartis for making the meeting such a great success.

• Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology, Harvard University Journey to the Edge of the Retina / Journey through the Depths of the Retina
• Mark Cahill, Clinical Lead, Global Vision, Royal Victoria Eye and Ear Hospital Diabetic Retina Screen Photography and Grading : Why, Where and How (it’s done)
• Reinhold Medina, M.D. Ph.D. Centre for Experimental Medicine Medicine, Dentistry & Biomedical Science, Queen’s University Belfast Potential Uses for Endothelial Progenitors in Diabetic Retinopathy
• David Keegan, PhD FRCOphth FRCSI(Oph) National Clinical Lead for Diabetic Retinopathy Transition to a National Diabetic Retinopathy Screening and Treatment Programme
• Robert Acheson, Clinical Lead, Mater Misericordiae University Hospital & Mater Private Hospital Diabetic Retina Screen – Arbitration and Gatekeeping

Corneal Stem Cell and Tissue Engineering.

The New Frontiers in Ophthalmology Meeting took place on Thursday 27th June 2013 in the Education & Conference Centre at the Royal Victoria Eye & Ear Hospital.

The morning of the meeting was devoted to a symposium on corneal stem cell and tissue engineering. The use of cell-based therapies in the management of ocular surface and corneal disorders is a new and rapidly evolving field with many potential disease applications. In this symposium the advances in the development of such therapies to restore the epithelial and endothelial corneal surfaces and the potential to transfer of these developments to the clinical setting were discussed.

Speakers included:

• Prof Conor Murphy (Royal Victoria Eye and Ear Hospital)
• Mr Billy Power (Royal Victoria Eye and Ear Hospital)
• Dr Clair Gallagher (National Institute of Cellular Biotechnology, Dublin City University)
• Dr Finbarr O’Sullivan (National Institute of Cellular Biotechnology, Dublin City University)
• Prof Fergal O’Brien (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
• Dr Andrew Cameron (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
• Dr Kevin Kavanagh (NUI Maynooth)
• Sinead Masterson (Irish Medicines Board)

The afternoon was devoted to the Eithne Walls Research Meeting, at which NCHDs presented their latest research in competition for the Eithne Walls Medal and the Research Foundation Clinical Prize.
The meeting was well attended and supported by a unrestricted educational grant from Novartis.

Read More..

Download the poster (PDF)